{"id":"W2047816645","doi":"10.1111/j.1542-4758.2009.00422.x","title":"Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial","year":2010,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Amgen (Canada); University of British Columbia","funders":"","keywords":"Medicine; Epoetin alfa; Anemia; Erythropoietin; Hemodialysis; Placebo; Internal medicine; Clinical trial; Darbepoetin alfa; Randomized controlled trial; Dialysis; Physical therapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003395218,0.0006585192,0.001886917,0.0004259246,0.0007793664,0.001066008,0.0006819034,0.0007814953,0.002029093],"category_scores_gemma":[0.004729853,0.0002314665,0.00230235,0.001098666,0.0005229072,0.0003973292,0.000385024,0.001162208,0.0001293491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002864488,"about_ca_system_score_gemma":0.008117683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1665507,"about_ca_topic_score_gemma":0.3541155,"domain_scores_codex":[0.9979656,0.0007722405,0.0001246901,0.000195407,0.0007263196,0.0002158845],"domain_scores_gemma":[0.9966114,0.0009443049,0.0006761262,0.0003136011,0.0007359375,0.0007186264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7468092,0.00253695,0.1483215,0.001339547,0.01583588,0.0002602235,0.0003016793,0.001260281,0.003017977,0.0007292905,0.01595755,0.06363001],"study_design_scores_gemma":[0.2932006,0.01175567,0.6673961,0.0001587178,0.01268909,0.0002554887,0.0001632256,0.001861951,0.0007242391,0.0004856722,0.01116253,0.0001466114],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9729823,0.008127389,0.0004977782,0.001158412,0.0002034399,0.00177223,0.009224652,0.0000399369,0.005993846],"genre_scores_gemma":[0.9833504,0.002396338,0.001178214,0.0008833292,0.0002455843,0.0008813689,0.009285934,0.00001387427,0.00176493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1665507,"threshold_uncertainty_score":0.3311625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009259313217867979,"score_gpt":0.2524040343688789,"score_spread":0.2431447211510109,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}